Optimal cytoreduction in stage IV ovarian carcinoma -: In reply

被引：0
|
作者：
Bonnefoi, H [1 ]
Gore, ME
机构：
[1] Univ Hosp Geneva, Geneva, Switzerland
[2] Royal Marsden Hosp, London SW3 6JJ, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1999年 / 17卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3004 / 3004
页数：1
相关论文
共 50 条
  • [21] To compare the optimal cytoreduction rate in advanced epithelial ovarian cancer stage III/IV after 3 versus 6 cycles of neoadjuvant chemotherapy
    Kumari, Archana
    Thakur, Monika
    Saha, S. C.
    Suri, Vanita
    Prasad, G. R. V.
    Patel, Firuza D.
    Radhika, S.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2021, 41 (04) : 616 - 620
  • [22] Tertiary cytoreduction in patients with recurrent ovarian carcinoma
    Leitao, MM
    Kardos, S
    Barakat, RR
    Chi, DS
    GYNECOLOGIC ONCOLOGY, 2004, 95 (01) : 181 - 188
  • [23] Secondary surgical cytoreduction for advanced ovarian carcinoma
    Rose, PG
    Nerenstone, S
    Brady, MF
    Clarke-Pearson, D
    Olt, G
    Rubin, SC
    Moore, DH
    Small, JM
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (24): : 2489 - 2497
  • [24] Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelia ovarian cancer - Discussion
    Dr Everett
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (02) : 575 - 576
  • [25] Is there a role for surgical cytoreduction in stage IV endometrial cancer?
    Munkarah, A
    GYNECOLOGIC ONCOLOGY, 2000, 78 (02) : 83 - 84
  • [26] Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer Reply
    Coleman, Robert L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (07): : 686 - 686
  • [27] Optimal cytoreduction for advanced epithelial ovarian cancer: A commentary
    Eisenkop, Scott M.
    Spirtos, Nick M.
    Lin, Wei-Chien Michael
    GYNECOLOGIC ONCOLOGY, 2006, 103 (01) : 329 - 335
  • [28] Immune signatures predictive of optimal cytoreduction in ovarian cancer
    Simons, E.
    Kiet, T.
    Amanam, I.
    Ho, M.
    Fuh, J.
    Fuh, K.
    Kapp, D.
    Odunsi, K.
    Chan, J.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S46 - S46
  • [29] Survival Outcomes of Patients with International Federation of Gynecology and Obstetrics Stage IV Ovarian Cancer: Cytoreduction Still Matters
    Xiao, Yao
    Linghu, Hua
    CANCER CONTROL, 2023, 30
  • [30] Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays
    Berchuck, A
    Iversen, ES
    Lancaster, JM
    Dressman, HK
    West, M
    Nevins, JR
    Marks, JR
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 190 (04) : 910 - 922
12345